| 1 | 11434939 | Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. | Surv Ophthalmol | 2001 May |
1 |
| 2 | 12606640 | Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). | J Pharmacol Exp Ther | 2003 May |
1 |
| 3 | 12664371 | Vasoactive properties of bimatoprost in isolated porcine ciliary arteries. | Klin Monbl Augenheilkd | 2003 Mar |
1 |
| 4 | 12724323 | Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression. | J Biol Chem | 2003 Jul 18 |
8 |
| 5 | 12854029 | Granulomatous anterior uveitis associated with bimatoprost: a case report. | Ocul Immunol Inflamm | 2003 Mar |
1 |
| 6 | 14729864 | Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. | J Lipid Res | 2004 Apr |
2 |
| 7 | 14757851 | Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. | J Pharmacol Exp Ther | 2004 May |
1 |
| 8 | 15016561 | Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. | Surv Ophthalmol | 2004 Mar |
1 |
| 9 | 15159280 | Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription. | Br J Pharmacol | 2004 Jun |
2 |
| 10 | 15179448 | Bimatoprost: a novel antiglaucoma agent. | Cardiovasc Drug Rev | 2004 Summer |
2 |
| 11 | 16249494 | The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. | Invest Ophthalmol Vis Sci | 2005 Nov |
1 |
| 12 | 16475787 | Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. | Biochemistry | 2006 Feb 21 |
6 |
| 13 | 17179945 | Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. | Br J Pharmacol | 2007 Feb |
1 |
| 14 | 17652738 | Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle. | Invest Ophthalmol Vis Sci | 2007 Aug |
1 |
| 15 | 17659482 | A historical perspective and recent advances in prostamide research and therapeutics. | Curr Opin Drug Discov Devel | 2007 Jul |
1 |
| 16 | 18587449 | Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. | Br J Pharmacol | 2008 Jul |
4 |
| 17 | 19323627 | Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. | J Ocul Pharmacol Ther | 2009 Apr |
1 |
| 18 | 19443729 | Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. | Invest Ophthalmol Vis Sci | 2009 Nov |
3 |
| 19 | 20028257 | Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea. | J Ocul Pharmacol Ther | 2009 Dec |
1 |
| 20 | 20054414 | Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides. | Clin Ophthalmol | 2009 |
1 |
| 21 | 20169887 | The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations. | Klin Oczna | 2009 |
1 |
| 22 | 20435598 | Cellular basis for bimatoprost effects on human conventional outflow. | Invest Ophthalmol Vis Sci | 2010 Oct |
1 |
| 23 | 20950588 | Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system. | Brain Res | 2011 Jan 7 |
2 |
| 24 | 23380599 | Prostaglandin ethanolamides attenuate damage in a human explant colitis model. | Prostaglandins Other Lipid Mediat | 2013 Jan |
3 |
| 25 | 23395963 | Bimatoprost protects retinal neuronal damage via Akt pathway. | Eur J Pharmacol | 2013 Feb 28 |
7 |
| 26 | 23801328 | Anandamide-derived prostamide F2α negatively regulates adipogenesis. | J Biol Chem | 2013 Aug 9 |
1 |
| 27 | 23893067 | Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics. | Pharmacol Rev | 2013 |
1 |
| 28 | 24102214 | Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition. | Br J Pharmacol | 2014 Mar |
3 |
| 29 | 25557612 | Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides. | Mol Carcinog | 2016 Feb |
2 |
| 30 | 25613811 | Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial. | BMC Ophthalmol | 2015 Jan 22 |
2 |
| 31 | 26335727 | Anandamide and decidual remodelling: COX-2 oxidative metabolism as a key regulator. | Biochim Biophys Acta | 2015 Nov |
1 |
| 32 | 26886889 | Bimatoprost Increases Mechanosensitivity of Trigeminal Ganglion Neurons Innervating the Inner Walls of Rat Anterior Chambers via Activation of TRPA1. | Invest Ophthalmol Vis Sci | 2016 Feb |
7 |
| 33 | 26956170 | Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. | BMC Ophthalmol | 2016 Mar 8 |
2 |
| 34 | 27011234 | Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways. | PLoS One | 2016 |
6 |
| 35 | 27124878 | Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis. | Dermatol Surg | 2016 May |
1 |
| 36 | 27552406 | Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? | Invest Ophthalmol Vis Sci | 2016 Aug 1 |
1 |
| 37 | 29034590 | Bimatoprost ophthalmic solution in facial vitiligo. | J Cosmet Dermatol | 2018 Jun |
4 |
| 38 | 29669171 | Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma. | Br J Pharmacol | 2019 Apr |
1 |
| 39 | 30080906 | Tear biomarkers in latanoprost and bimatoprost treated eyes. | PLoS One | 2018 |
2 |
| 40 | 30551199 | The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy. | Invest Ophthalmol Vis Sci | 2018 Dec 3 |
1 |
| 41 | 30580056 | In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells. | Ann Anat | 2019 Mar |
2 |
| 42 | 30884982 | Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells. | Curr Eye Res | 2019 Aug |
2 |
| 43 | 31462124 | Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018). | Expert Opin Ther Pat | 2019 Oct |
1 |
| 44 | 32222455 | Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells. | Exp Eye Res | 2020 May |
3 |
| 45 | 34044522 | [Bimatoprost promotes hair growth of reconstructed hair follicles in mice through activation of the Wnt/β-catenin signaling pathway]. | Zhonghua Yi Xue Za Zhi | 2021 Jun 1 |
5 |
| 46 | 35394456 | A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study. | J Glaucoma | 2022 Jun 1 |
1 |